Analog insulin detemir for patients with type 1 and type 2 diabetes: a review. - Wikidata - awgldk - TriplyDB

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

http://www.wikidata.org/entity/Q37857693

about

Type 2 diabetes mellitus management and body mass index: experiences with initiating insulin detemir in the a1chieve study Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.

P2860

Q33785184-323F0D6F-296C-477E-BBB9-CCE79EB904FE Q37468419-5E78708E-F625-43BC-8148-71A086DA7A40

P2860

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

http://www.wikidata.org/entity/Q37857693

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

@en

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

@nl

type

label

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

@en

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

@nl

prefLabel

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

@en

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

@nl

P1433

Q37857693-3BE7E80D-8DFA-44C9-86D9-2BA0A04CE5FF

P1476

Q37857693-2A425270-EDD2-47ED-A065-26E1470A2C7A

P2093

Q37857693-878F449B-6165-4838-8359-F6B7E0BC07F7

P2860

Q37857693-0CCB9E76-6114-4A27-B2B7-DD1318D4867B

Q37857693-1A0EDA67-6A37-43C4-A39C-0378C0CF0FDA

Q37857693-2A80B034-044E-4875-B06F-4E198579F951

Q37857693-2BA8CE6C-DF4C-4438-8741-95958F506F17

Q37857693-2C329FBF-DE96-4358-A9EB-426F441FCAA9

Q37857693-36E4B657-A8D7-4EE7-9D74-2BF0E5712558

Q37857693-4553323B-0123-4E48-B2F3-A64F1B10E31D

Q37857693-457DCF52-5093-4B08-8225-20DBEAE33BDA

Q37857693-479A190F-F1EC-41CC-91DA-C0B483616BEC

Q37857693-5BC2DF88-CFB2-4929-937F-C10984422DA6

P304

Q37857693-469A226D-C6C7-4B26-AC96-EB59BE1B9A14

P31

Q37857693-6CD85EBA-DE58-440C-A222-75DED1819915

P356

Q37857693-6244BC71-3A80-4254-A66C-895E3662C7FF

P478

Q37857693-447BEDB2-FC1D-48FC-B4C4-DC1995AF83EB

P577

Q37857693-FF32EE98-87F5-47E0-B6C7-2E94AD7EFF23

P698

Q37857693-DEBBEDB7-8336-4035-B1F3-7FC788748D52

P921

Q37857693-45E026BF-8A90-41A5-AAFB-F837D8BE5D52

Q37857693-B7E29854-10D4-479D-B118-67C1895EA3E9

P932

Q37857693-0BC881BD-C495-4BD5-865F-5F6CBB400DA0

P356

P1433

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

P1476

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.

@en

P2093

Gregory E Peterson

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis.

Should minimal blood glucose variability become the gold standard of glycemic control?

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Targeting postprandial hyperglycemia.

Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.

Comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes: assessment of detemir administration in a progressive treat-to-target trial (ADAPT).

Glycemic control in diabetes: a tale of three studies.

Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes.

P304

31-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DMSOTT.S3401

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21437117

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

type-2 diabetes

P932

3047999

http://www.w3.org/2001/XMLSchema#string